A 12-week randomized double-blind placebo-controlled trial investigating the effects of Levetiracetam in early psychosis

Brief description of study

A 12-week randomized, double-blind, placebo-controlled trial investigating the effects of Levetiracetam in early psychosis


Clinical Study Identifier: s19-01820
ClinicalTrials.gov Identifier: NCT04317807
Principal Investigator: Donald C Goff.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.